Slingshot members are tracking this event:
AbbVie Announces Positive Top-Line Results From Second Phase 3 Study Investigating Elagolix in Patients with Endometriosis
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 10, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Replicate Pivotal Phase 3 Clinical Trials, Top-line Results, Elagolix, Endometriosis